Market Cap 3.74M
Revenue (ttm) 0.00
Net Income (ttm) -2.54M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 313,400
Avg Vol 1,193,022
Day's Range N/A - N/A
Shares Out 1.50M
Stochastic %K 2%
Beta 0.50
Analysts Strong Buy
Price Target N/A

Latest News on CERO

CERo Therapeutics, Inc. Appoints Chris Ehrlich CEO

Dec 6, 2024, 9:00 AM EST - 6 weeks ago

CERo Therapeutics, Inc. Appoints Chris Ehrlich CEO


CERo Therapeutics, Inc. Provides Corporate Update

Oct 21, 2024, 9:00 AM EDT - 3 months ago

CERo Therapeutics, Inc. Provides Corporate Update


Dow Tumbles Over 200 Points; CERo Therapeutics Shares Jump

Sep 25, 2024, 2:49 PM EDT - 4 months ago

Dow Tumbles Over 200 Points; CERo Therapeutics Shares Jump